Bismuth combo therapy for stomach bug under review

NCT ID NCT07167511

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked back at medical records of 1,730 adults with H. pylori infection who received bismuth-containing quadruple therapy as their first treatment. Researchers compared how well different drug combinations worked and what side effects occurred. The goal was to identify which regimen works best in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bismuth-containing quadruple therapy

What this could lead to

If successful, this could help doctors choose the best bismuth-based combination to treat H. pylori infections more effectively.

What could go wrong

This is a retrospective review, not a controlled trial, so results may be less reliable. It also does not test a new treatment, only compares existing ones.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Helicobacter pylori infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012, China